Perianal Nerval Block in Proctological Interventions
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03405922 |
|
Recruitment Status :
Completed
First Posted : January 23, 2018
Last Update Posted : July 10, 2019
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Perianal Fistula Fissure in Ano Hemorrhoids | Drug: Placebo 40 mL Saline 0.9% Drug: 40 mL Ropivacain 0.5% | Phase 4 |
The aim of this study is to evaluate whether a local perianal block performed during a proctological intervention can reduce the postoperative pain.
All patients will undergo surgery under general or spinal anesthesia. At the end of the surgery, the surgeon will perform a perianal block using the local anesthetic or the placebo upon randomisation. The experimental group will receive a local anesthetics and the control group a normal saline injection. All injections will be perianal, peripheral to the external anal sphincter.
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 166 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | Double (Participant, Care Provider) |
| Primary Purpose: | Treatment |
| Official Title: | Perianal Nerval Block in Proctological Interventions: a Prospective Randomized Double Blinded Study |
| Actual Study Start Date : | February 1, 2018 |
| Actual Primary Completion Date : | July 5, 2019 |
| Actual Study Completion Date : | July 5, 2019 |
| Arm | Intervention/treatment |
|---|---|
|
Placebo Comparator: Placebo
Placebo 40 mL Saline 0.9%
|
Drug: Placebo 40 mL Saline 0.9%
Injection of 40 mL 0.9% saline |
|
Active Comparator: Ropivacain
40 mL Ropivacain 0.5%
|
Drug: 40 mL Ropivacain 0.5%
Ropivacaine Hcl 0.5% Injection 40 mL |
- Postoperative Pain [ Time Frame: 24 hours post-surgery ]Postoperative Pain assessed by visual analogue scale (max. 10, min.0 points, range: 0-10; 0 = no pain at all, 10 = worst pain ever experienced)
- Quality of Life assessed by questionnaire [ Time Frame: 2 weeks post-surgery ]Quality of Life assessed by questionnaire
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Patients with surgical indication for hemorrhoids, fistula-in-ano or anal fissures.
- Age of 18 or above
Exclusion Criteria:
- age under 18.
- Patients unable to understand an informed consent.
- Emergency operations
- Pregnant women.
- Patients with acute perianal infection.
- Patients allergic to any component of the local anesthetic
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03405922
| Switzerland | |
| St Claraspital | |
| Basel, Switzerland, 4016 | |
| Principal Investigator: | Daniel Steinemann | St:Claraspital |
| Responsible Party: | University Hospital, Basel, Switzerland |
| ClinicalTrials.gov Identifier: | NCT03405922 |
| Other Study ID Numbers: |
Perianal block in proctology |
| First Posted: | January 23, 2018 Key Record Dates |
| Last Update Posted: | July 10, 2019 |
| Last Verified: | July 2019 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
| Product Manufactured in and Exported from the U.S.: | No |
|
Hemorrhoids Fissure in Ano Fistula Pathological Conditions, Anatomical Rectal Diseases Intestinal Diseases |
Gastrointestinal Diseases Digestive System Diseases Vascular Diseases Cardiovascular Diseases Anus Diseases |

